Literature DB >> 28325176

Therapeutics for Equine Gastric Ulcer Syndrome.

Fereydon Rezazadeh Zavoshti1, Frank M Andrews2.   

Abstract

Equine gastric ulcer syndrome (EGUS) is an umbrella term used to describe ulcers in the nonglandular squamous and glandular mucosa, terminal esophagus, and proximal duodenum. Gastric ulcers in the squamous and glandular regions occur more often than esophageal or duodenal ulcers and likely have a different pathogenesis. At present, omeprazole is accepted globally as the best pharmacologic therapy for both regions of the stomach; however, the addition of coating agents and synthetic prostaglandins could add to its effectiveness in treatment of EGUS. Dietary and environmental management are necessary for prevention of recurrence.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Equine; Equine gastric ulcer syndrome; Gastric ulcer; Horse; Therapeutics

Mesh:

Substances:

Year:  2017        PMID: 28325176     DOI: 10.1016/j.cveq.2016.11.004

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  3 in total

1.  Risk Factors for Recurrence of Peptic Ulcer Disease: A Retrospective Study in Tertiary Care Referral Center.

Authors:  Yaser M Alsinnari; Mohammed S Alqarni; Meshari Attar; Ziad M Bukhari; Mohammed Almutairi; Faisal M Baabbad; Mohammed Hasosah
Journal:  Cureus       Date:  2022-02-07

2.  Clinical observation of magnesium aluminum carbonate combined with rabeprazole-based triple therapy in the treatment of helicobacter pylori-positive gastric ulcer associated with hemorrhage.

Authors:  Peng-Zhe Zhou; Lei Gao; Li-Wei Wang; Ying-Fu Zhang; Wei-Li Song; Ying-Xia Hao
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

3.  Effect of oral administration of omeprazole on the microbiota of the gastric glandular mucosa and feces of healthy horses.

Authors:  Simona Cerri; Bernard Taminiau; Alexandra Hache-Carré de Lusancay; Laureline Lecoq; Hélène Amory; Georges Daube; Carla Cesarini
Journal:  J Vet Intern Med       Date:  2020-10-16       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.